Circulating Glial-derived neurotrophic factor is reduced in late-life depression

Journal of Psychiatric Research

Volumn 46, Issue 1, 2012, Pages 135-139

  Diniz, Breno S ^a   Teixeira, Antonio L ^b   Miranda, Aline S ^b   Talib, Leda L ^a   Gattaz, Wagner F ^a   Forlenza, Orestes V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

GDNF; Late life depression; Neurotrophic cascades; Physiopathology

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; ONSET AGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS;

EID: 81855185296     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.09.007     Document Type: Article

References (47)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, (DSM-IV). 4th ed 2000, American Psychiatric Association, Washington, D.C.
2. Airaksinen M.S., Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nature Reviews of Neuroscience 2002, 3:383-394.
3. Alexopoulos G.S., Meyers B.S., Young R.C., Campbell S., Silbersweig D., Charlson M. 'Vascular depression' hypothesis. Archives of General Psychiatry 1997, 54:915-922.
4. Alladi P.A., Mahadevan A., Shankar S.K., Raju T.R., Muthane U. Expression of GDNF receptors GFRalpha1 and RET is preserved in substantia nigra pars compacta of aging Asian Indians. Journal Chemical Neuroanatomy 2010, 40:43-52.
5. Alleva E., Francia N. Psychiatric vulnerability: suggestions from animal models and role of neurotrophins. Neuroscience and Biobehavioral Reviews 2009, 33:525-536.
6. Barbosa I.G., Huguet R.B., Sousa L.P., Abreu M.N., Rocha N.P., Bauer M.E., et al. Circulating levels of GDNF in bipolar disorder. Neuroscience Letters 2011, 502:103-106.
7. Brunoni A.R., Lopes M., Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. International Journal of Neuropsychopharmacology 2008, 11:1169-1180.
8. Chen A.C., Eisch A.J., Sakai N., Takahashi M., Nestler E.J., Duman R.S. Regulation of GFRalpha-1 and GFRalpha-2 mRNAs in rat brain by electroconvulsive seizure. Synapse 2001, 39:42-50.
9. Cunningham C., Campion S., Lunnon K., Murray C.L., Woods J.F., Deacon R.M., et al. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biological Psychiatry 2009, 65:304-312.
10. Dass B., Kladis T., Chu Y., Kordower J.H. RET expression does not change with age in the substantia nigra pars compacta of rhesus monkeys. Neurobiology of Aging 2006, 27:857-861.
11. de Sousa R.T., van de Bilt M.T., Diniz B.S., Ladeira R.B., Portela L.V., Souza D.O., et al. Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study. Neuroscience Letters 2011, 494:54-56.
12. Diniz B.S., Nunes P.V., Yassuda M.S., Pereira F.S., Flaks M.K., Viola L.F., et al. Mild cognitive impairment: cognitive screening or neuropsychological assessment?. Revista Brasileira de Psiquiatria 2008, 30:316-321.
13. Diniz B.S., Teixeira A.L., Talib L.L., Mendonca V.A., Gattaz W.F., Forlenza O.V. Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression. World Journal of Biological Psychiatry 2010, 11:550-555.
14. Diniz B.S., Teixeira A.L., Talib L., Gattaz W.F., Forlenza O. Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. American Journal of Geriatric Psychiatry 2010, 18:172-176.
15. Diniz B.S., Teixeira A.L., Talib L.L., Mendonça V.A., Gattaz W.F., Forlenza O.V. Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression. Journal of Psychiatric Research 2010, 44:917-920.
16. Diniz B.S., Teixeira A.L., Ojopi E.B., Talib L.L., Mendonca V.A., Gattaz W.F., et al. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's Disease. Journal of Alzheimer's Disease 2010, 22:1305-1311.
17. Diniz B.S., Talib L.L., Joaquim H.P., de Paula V.R., Gattaz W.F., Forlenza O.V. Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment?. World Journal of Biological Psychiatry 2011, 12:216-222.
18. First M.B., Spitzer Robert L., Gibbon Miriam, Williams Janet B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P) 2002, Biometrics Research, New York State Psychiatric Institute, New York.
19. Folstein M.F., Folstein S.E., McHugh P.R. " Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
20. Forlenza O.V., Diniz B.S., Talib L.L., Radanovic M., Yassuda M.S., Ojopi E.B., et al. Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment. Revista Brasileira de Psiquiatria 2010, 32:216-222.
21. Forlenza O.V., Diniz B.S., Teixeira A.L., Ojopi E.B., Talib L.L., Mendonca V.A., et al. Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World Journal of Biological Psychiatry 2010, 11:774-780.
22. Franceschi C., Bonafo M., Valensin S., Olivieri F., De Luca M., Ottaviani E., et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Annals of the New York Academy of Sciences 2000, 908:244-254.
23. Golan M., Schreiber G., Avissar S. Antidepressants elevate GDNF expression and release from C6 glioma cells in a beta-arrestin1-dependent, CREB interactive pathway. International Journal of Neuropsychopharmacology 2011, [epub ahead of print]. 10.1017/S1461145710001550.
24. Hamilton M. A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry 1960, 23:56-62.
25. Hisaoka K., Nishida A., Koda T., Miyata M., Zensho H., Morinobu S., et al. Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells. Journal of Neurochemistry 2001, 79:25-34.
26. Hisaoka K., Tsuchioka M., Yano R., Maeda N., Kajitani N., Morioka N., et al. Tricyclic antidepressant amitriptyline activates fibroblast growth factor receptor signaling in glial cells: involvement in glial cell line-derived neurotrophic factor production. Journal of Biological Chemistry 2011, 286:21118-21128.
27. Lee T.H., Yang J.T., Kato H., Wu J.H. Hypertension downregulates the expression of brain-derived neurotrophic factor in the ischemia-vulnerable hippocampal CA1 and cortical areas after carotid artery occlusion. Brain Research 2006, 1116:31-38.
28. Leyhe T., Stransky E., Eschweiler G.W., Buchkremer G., Laske C. Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease. European Archives of Psychiatry and Clinical Neuroscience 2008, 258:124-128.
29. Meltzer C.C., Price J.C., Mathis C.A., Butters M.A., Ziolko S.K., Moses-Kolko E., et al. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 2004, 29:2258-2265.
30. Michel T.M., Frangou S., Camara S., Thiemeyer D., Jecel J., Tatschner T., et al. Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: a comparative post-mortem study. European Psychiatry 2008, 23:413-420.
31. Nunes P.V., Diniz B.S., Radanovic M., Abreu I.D., Borelli D.T., Yassuda M.S., et al. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education. International Journal of Geriatric Psychiatry 2008, 23:1127-1133.
32. Otsuki K., Uchida S., Watanuki T., Wakabayashi Y., Fujimoto M., Matsubara T., et al. Altered expression of neurotrophic factors in patients with major depression. Journal of Psychiatric Research 2008, 42:1145-1153.
33. Pascual A., Hidalgo-Figueroa M., Piruat J.I., Pintado C.O., Gomez-Diaz R., Lopez-Barneo J. Absolute requirement of GDNF for adult catecholaminergic neuron survival. Nature Neuroscience 2008, 11:755-761.
34. Rosa A.R., Frey B.N., Andreazza A.C., Cereser K.M., Cunha A.B., Quevedo J., et al. Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neuroscience Letters 2006, 407:146-150.
35. Roth M., Tym E., Mountjoy C.Q., Huppert F.A., Hendrie H., Verma S., et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry 1986, 149:698-709.
36. Sheline Y.I., Mintun M.A., Barch D.M., Wilkins C., Snyder A.Z., Moerlein S.M. Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography. Neuropsychopharmacology 2004, 29:2235-2241.
37. Straten G., Eschweiler G.W., Maetzler W., Laske C., Leyhe T. Glial cell-line derived neurotrophic factor (GDNF) concentrations in cerebrospinal fluid and serum of patients with early Alzheimer's disease and normal controls. Journal of Alzheimer's Disease 2009, 18:331-337.
38. Straten G., Schmeer C., Kretz A., Gerhardt E., Kugler S., Schulz J.B., et al. Potential synergistic protection of retinal ganglion cells from axotomy-induced apoptosis by adenoviral administration of glial cell line-derived neurotrophic factor and X-chromosome-linked inhibitor of apoptosis. Neurobiology of Disease 2002, 11:123-133.
39. Takebayashi M., Hisaoka K., Nishida A., Tsuchioka M., Miyoshi I., Kozuru T., et al. Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. International Journal of Neuropsychopharmacology 2006, 9:607-612.
40. Tapia-Arancibia L., Aliaga E., Silhol M., Arancibia S. New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Research Reviews 2008, 59:201-220.
41. Teixeira A.L., Barbosa I.G., Diniz B.S., Kummer A. Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomarkers in Medicine 2010, 4:871-887.
42. Uchida S., Hara K., Kobayashi A., Otsuki K., Yamagata H., Hobara T., et al. Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron 2011, 69:359-372.
43. Wang X., Hou Z., Yuan Y., Hou G., Liu Y., Li H., et al. Association study between plasma GDNF and cognitive function in late-onset depression. Journal of Affective Disorders 2011, 132:418-421.
44. Yu H., Zhang Z., Shi Y., Bai F., Xie C., Qian Y., et al. Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. Journal of Clinical Psychiatry 2008, 69:1104-1111.
45. Zhang X., Zhang Z., Sha W., Xie C., Xi G., Zhou H., et al. Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression. Psychiatry Research 2009, 170:273-275.
46. Zhang X., Zhang Z., Sha W., Xie C., Xi G., Zhou H., et al. Effect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patients. Journal of Affective Disorders 2010, 126:326-329.
47. Zhang X., Zhang Z., Xie C., Xi G., Zhou H., Zhang Y., et al. Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biological Psychiatry 2008, 32:886-890.